Osimert.com is intended to provide accessible pharmaceutical information about Osimert 80 mg (osimertinib) and the medical context surrounding osimertinib.
The website is designed to explain pharmaceutical terminology, treatment indications, administration, safety information, clinical evidence, product identification and manufacturer relationships in language that can be understood by general readers while retaining medically relevant terminology.
Editorial approach
The content is organized around authoritative regulatory and scientific sources, including regulatory agencies, prescribing information, peer-reviewed literature and manufacturer information.
Medical information is reviewed for:
- Accuracy
- Source quality
- Medicine-specific relevance
- Regulatory context
- Safety
- Clarity
- Date sensitivity
Source transparency
Where appropriate, information is linked to or attributed to authoritative sources such as the FDA, EMA, DailyMed, PubMed and the manufacturer’s official documentation.
No invented credentials
Osimert.com does not claim that its content has been written or reviewed by a doctor, pharmacist or other healthcare professional unless the identity and credentials of such a reviewer have been independently verified and specifically published.
Updates
Drug labels, regulatory approvals and safety information can change. Readers should consult the latest official prescribing information applicable to their country before making treatment decisions.
Medical disclaimer
The information on this website is educational. It does not replace consultation with a qualified healthcare professional.